Research & Development
Policy & Regulation
Trends & Finance
Lab billing firm settles lawsuit related to unnecessary COVID-19 testing
For one chain of communities, a laboratory directed the company to bill Medicare for respiratory pathogen panels ordered by a physician who had not ordered the tests.
June 20, 2023
Bio-Techne files patent infringement lawsuit
Bio-Techne alleged that Molecular Instruments' HCR 3.0 technology infringes on Bio-Techne's European Patents (U.K.) 2,500,439 and 1,910,572 for the RNAscope ISH technology.
September 25, 2022
‘Father of microarray technology’ convicted in $77M fraud scheme
Mark Schena participated in a scheme to mislead investors, commit healthcare fraud, and pay illegal kickbacks in connection with the submission of more than $77 million in false and fraudulent claims for such testing, the U.S. Department of Veterans Affairs (VA), Office of Inspector General (OIG), announced Thursday.
September 8, 2022
Florida lab owner charged in $53M fraud, kickback scheme
Daniel Hurt of Fort Lauderdale, FL, is charged with one count of conspiracy to commit healthcare fraud and had his initial appearance and arraignment by videoconference on Tuesday in a Newark, NJ, federal court, according to the DOJ U.S. Attorney's Office, District of New Jersey.
August 30, 2022
Personalis sues Foresight Dx for patent infringement
The Menlo Park, CA-based company is seeking both injunctive relief and monetary damages based upon Foresight's infringement of Personalis' U.S. Patents 10,450,611; 11,299,783; and 11,384,394.
August 2, 2022
Video from AACC: AACC president on Theranos, VALID Act
Dr. Master discussed key takeaways from a fireside chat he moderated on Tuesday involving two of the whistleblowers who helped bring down Theranos, as well as the implications of the VALID Act for laboratories and IVD companies.
July 31, 2022
Lab providers to pay $5.7M to settle testing allegations
The U.S. Department of Justice (DOJ) charged that Metric Lab Services, Metric Management Services, Spectrum Diagnostic Labs, and owners Sherman Kennerson and Jeffrey Madison prompted the submission of false Medicare claims by paying kickbacks in return for genetic testing samples.
July 24, 2022
Theranos whistleblowers to speak at AACC Expo
Cheung and Shultz will discuss the ethical challenges they faced in their efforts to reveal Theranos' fraud and to protect patients from the company's faulty tests, AACC said.
June 28, 2022
Founders of 3 lab companies indicted in $300M fraud
According to the indictment, Unified Laboratory Services and Spectrum Diagnostic Laboratory Founder Jeffrey Paul Madison and Chief Operating Officer Mark Christopher Boggess, as well as Reliable Labs Co-Founders Biby Ancy Kurian and Abraham Phillips, allegedly paid kickbacks to induce medical professionals to order medically unnecessary lab tests. They then billed the tests to Medicare and other federal healthcare programs, according to U.S. Attorney for the Northern District of Texas Chad Meacham.
February 15, 2022
Lab owner pleads guilty to fraud charge for genetic tests
Federal investigators said that Christopher Licata pleaded guilty to paying patient brokers to secure referrals from doctors for orders authorizing medically unnecessary genetic testing to Licata's laboratory, Boca Toxicology (dba Lab Dynamics). Licata and his lab would then bill Medicare for the tests, according to authorities.
January 13, 2022
Bogus testing kickback scheme results in guilty plea
Elizabeth Turner, the owner of Advanced Tele-Genetic Counseling, pleaded guilty to healthcare fraud conspiracy in the U.S. District Court in Nashville. Her company received approximately $234,730 in illegal kickback payments, according to a press release issued by the U.S. Attorney's Office of the Middle District of Tennessee.
December 21, 2021
Lab owner sentenced to 82 months over COVID kickback scheme
Court documents say Leonel Palatnik of Aventura, FL, allegedly conspired with co-owners of Panda Conservation Group, and with Michael Stein, the owner of 1523 Holdings, to pay illegal kickbacks to Stein in exchange for his work arranging for telemedicine providers to authorize genetic testing orders for Panda's laboratories.
November 11, 2021
Page 1 of 2